CompPair secures funding to grow commercial activities for HealTech composite

CompPair Technologies (Renens, Switzerland) recently closed a funding round that is strengthening the company’s activities, expanding its team and will support the company’s growth in the composites sector. The round was led by existing shareholders and completed by new investors. CompPair also notes complimentary funding from public entities, InnoSuisse and Eurostar.

“I am delighted to represent CompPair as president of the board of directors,” says Marie Ivorra Grosse, ex-CEO of RUAG Space (now Beyond Gravity). “Over the past 2 years in this role, I have witnessed CompPair’s transformation from a spin-off company to a thriving entity with a strong industrial presence and commitment to delivering sustainable composite products. This financing marks a pivotal moment, propelling the company to the next growth stage.”

CompPair is a solution provider, bringing embedded, ultra-fast repair to all composite applications. Founded 4 years ago, the Swiss company has launched three product lines, including prepregs and liquid compression molding (LCM) processes, also adapted to sandwich structures. CompPair’s HealTech technology, for instance, enables in-situ repair in only a couple of minutes while maintaining the component/structure’s same properties.  Several economic and environmental benefits have been demonstrated, the company reports, including cost savings, CO₂ emission reductions, faster repairs, impact and fatigue healing, improved crack resistance and an efficient recycling process at end of life. HealTech has demonstrated global interest ranging from sports, leisure, luxury and energy to industrial and aerospace applications. 

Inspired by nature, CompPair’s goal is to extend the lifetime of composite parts in order to prevent unnecessary waste. In addition to these solution offerings, CompPair brings expertise in eco-design and repair, prototyping and production capacity.

This investment round, coinciding with substantial public funding from entities like InnoSuisse, will enable the company to reach commercial implementation milestones. A portion of the funding constitutes a Swiss Accelerator innovation project supported by Innosuisse, to develop low-viscosity resin formulations. The remaining funding is allocated to a Eurostar program dedicated to the advancement of bio-based resins. Anticipated outcomes are the availability of complementary, off-the-shelf products on the market and the opening of new market perspectives. The funding will also accelerate the operation of CompPair’s industrial-scale production capacity.

Since its foundation in early 2020, CompPair has received strong support from both the Swiss and international startup scene, winning numerous
awards and non-dilutive funding. Noteworthy milestones include CompPair’s selection for the ESA BIC program, which has grown into current activities with the European Space Agency (ESA) on diverse aerospace projects. In 2021, CompPair also won the JEC Composites Startup Booster. HealTech has received the Solar Impulse label, attesting to its sustainable and economic viability. In 2022, CompPair was awarded with the Prix Strategis award, recognizing the “Best Swiss Startup.” 

The company has increased its client base within the composites industry through several implementations across the sports, leisure, aerospace and mobility fields.